tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Income Statement

Compare
597 Followers

Cue Biopharma Income Statement

Last quarter (Q3 2024), Cue Biopharma's total revenue was $3.34M, an increase of 58.86% from the same quarter last year. In Q3, Cue Biopharma's net income was $-8.66M. See Cue Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.49M$ 1.25M$ 14.94M$ 3.15M$ 3.46M
Gross Profit
$ -32.61M$ -560.83K$ 16.72M$ -30.39M$ -24.03M
Operating Expenses
$ 19.54M$ 54.75M$ 58.65M$ 48.20M$ 40.23M
Depreciation and Amortization
$ 3.44M$ 1.81M$ -1.78M$ 1.06M$ 5.35M
EBITDA
$ -46.05M$ -50.49M$ -45.44M$ -43.99M$ -35.96M
Operating Income
$ -52.15M$ -53.22M$ -43.71M$ -45.04M$ -36.77M
Other Income/Expenses
$ 1.42M$ 215.00K$ 45.90K$ 463.91K$ 482.79K
Pretax Income
$ -50.73M$ -53.01M$ -43.67M$ -44.58M$ -36.29M
Net Income
$ -50.73M$ -52.80M$ -44.16M$ -44.78M$ -36.70M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.11$ -1.48$ -1.41$ -1.56$ -1.66
Diluted EPS
$ -1.11$ -1.48$ -1.41$ -1.56$ -1.66
Weighted Average Shares Outstanding
45.75M 35.65M 31.29M 28.69M 22.04M
Weighted Average Shares Outstanding (Diluted)
45.75M 35.65M 31.29M 28.69M 22.04M
Currency in USD

Cue Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis